Clinical Trial Update: A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Zanubrutinib with Bendamustine plus Rituximab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeiGene | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-11-07